Jump to main content or area navigation.

Contact Us

Technology Transfer Network - OAR Policy and Guidance

OAR Policy and Guidance Metarecord

Document Title/Subject:
Proposal Preamble: NESHAP for Pharmaceutical Products
Related Documents:
Proposed Rule-Pharm. Production
Signed by: Carol Browner, Administrator

Signature Date:

Contact:
Randy McDonald
Emission Standards Division, OAQPS
MD-13

Filename(s):
URL(s):
http://www.epa.gov/ttn/oarpg/t3/fr_notices/phar_pre.zip

 

Regulatory Authority:
Title 3

Division:
Emission Standards Division (OAQPS)
Submitted By:
devereux.curt
Document Type:
Proposed & Final Preambles & Rules
EPA Document Number:

Federal Register:
62 FR 15754 04/02/97
Supersedes:
Subject Category:
AIR
WASTES
Keywords:
Hazardous air pollutants
HAPs
Volatile organic compounds
VOCs
Wastewater treatment
Terms:
Air pollutants
Clean Air Act
CAA
Abstract:
This document contains the Preamble explaining a proposed standard which would reduce air emissions of hazardous air pollutants (HAP) from existing and new facilities that manufacture pharmaceutical products. The agency intends that this proposed rule will have a common technology basis with a rule yet to be issued by EPA's Office of Water (OW); this will allow coordinated and cost effective compliance planning by the industry. In addition to soliciting comments on various aspects of the proposed rule, this document also solicits comments on possible approaches for the OW rule.
Facilities covered by this proposed rule include methylene chloride, methanol, toluene, and hydrogen chloride. Methylene chloride is considered to be a human carcinogen and the other pollutants can cause noncancer health effects in humans. The proposed rule is estimated to reduce HAP emissions from existing facilities by 22,000 megagrams per year (Mg/yr). It also reduces volatile organic compound (VOC) emissions. (98KB in WP format)

File Utilities

Jump to main content.